Drug Type Inactivated vaccine, Prophylactic vaccine |
Synonyms Influenza vaccine (surface antigen, inactivated, prepared in cell cultures), Influenza virus A/turkey/Turkey/1/2005 (H5N1) NIBRG-23 strain, HA surface antigen, Celldemic + [1] |
Target- |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date EU (19 Apr 2024), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
influenza A subtype H5N1 infection | EU | 19 Apr 2024 | |
influenza A subtype H5N1 infection | IS | 19 Apr 2024 | |
influenza A subtype H5N1 infection | LI | 19 Apr 2024 | |
influenza A subtype H5N1 infection | NO | 19 Apr 2024 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Influenza, Human | NDA/BLA | EU | 22 Feb 2024 |